These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31714685)

  • 1. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
    An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
    Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms to predict survival outcomes after microwave ablation in elderly patients (>65 years old) with early-stage hepatocellular carcinoma.
    Huang Z; Gu Y; Zhang T; Wu S; Wang X; An C; Huang J
    Int J Hyperthermia; 2020; 37(1):808-818. PubMed ID: 32619374
    [No Abstract]   [Full Text] [Related]  

  • 4. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
    Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
    Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a clinicopathological-based nomogram to predict seeding risk after percutaneous thermal ablation of primary liver carcinoma.
    An C; Huang Z; Ni J; Zuo M; Jiang Y; Zhang T; Huang JH
    Cancer Med; 2020 Sep; 9(18):6497-6506. PubMed ID: 32702175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    Kim CG; Lee HW; Choi HJ; Lee JI; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim HS; Kim KH; Choi SJ; Kim Y; Lee KS; Kim GM; Kim MD; Won JY; Lee DY; Kim BK
    Cancer Med; 2019 Sep; 8(11):5023-5032. PubMed ID: 31290618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.
    Yuan Z; Wang Y; Hu C; Gao W; Zheng J; Li W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818801362. PubMed ID: 30244651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Nomogram for Patients with Hepatocellular Carcinoma After Thermal Ablation.
    Ding M; Zhao X; Zhao M; Shi Y; Wang T; Cui D; Shi D; Zhai B
    Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1621-1630. PubMed ID: 32814990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
    Lee S; Han S; Shim JH; Kim SY; Won HJ; Shin YM; Kim PN; An J; Lee D; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
    J Vasc Interv Radiol; 2015 Dec; 26(12):1787-94.e1. PubMed ID: 26542708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study.
    Lu N; Sheng S; Xiong Y; Zhao C; Qiao W; Ding X; Chen J; Zhang Y
    Front Immunol; 2024; 15():1459740. PubMed ID: 39315112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.
    Chinnaratha MA; Sathananthan D; Pateria P; Tse E; MacQuillan G; Mosel L; Pathi R; Madigan D; Wigg AJ
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):349-54. PubMed ID: 25563141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
    Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
    BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.
    Shen J; He L; Li C; Wen T; Chen W; Lu C; Yan L; Li B; Yang J
    Oncotarget; 2016 Dec; 7(49):80783-80793. PubMed ID: 27811374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 18. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
    Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
    Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.
    Feng LH; Dong H; Lau WY; Yu H; Zhu YY; Zhao Y; Lin YX; Chen J; Wu MC; Cong WM
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):293-303. PubMed ID: 27743138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.